Drug Trial Radar · NCT00002802
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
Last checked: Nov 20, 2026Latest source record: Dec 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Planned (sponsor's estimate)
Start
Jul 1990
Primary completion
Not stated
Study completion Sep 2003
Sponsor
- Lead sponsor
- Children's Hospital Medical Center, CincinnatiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 12, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which treatment regimen is most effective in treating patients with different stages of and risk factors for neuroblastoma. PURPOSE: Phase III trial to study the effectiveness of therapy based on stage of disease and risk assessment in treating children with neuroblastoma.
Conditions
- Neuroblastoma
Interventions
carboplatinDrug
cisplatinDrug
cyclophosphamideDrug
dacarbazineDrug
doxorubicin hydrochlorideDrug
etoposideDrug
ifosfamideDrug
melphalanDrug
mesnaDrug
vincristine sulfateDrug
vindesineDrug
autologous bone marrow transplantationProcedure
conventional surgeryProcedure
low-LET cobalt-60 gamma ray therapyRadiation
low-LET electron therapyRadiation
low-LET photon therapyRadiation
radioisotope therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Cologne
Frechen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.